The American Herbal Pharmacopoeia (AHP) is proposing to develop four AHP Monographs and Therapeutic Compendiums for the three individual Triphala fruits (Phyllanthus emblica, Terminalia bellirica, Terminalia chebula) and the Triphala combination. Terminalia bellirica has just been published.
The individual fruits in Triphala are some of the most important herbal compounds in the Ayurvedic materia medica and Triphala is by far the most important formula in Ayurveda for promoting human health. It is used in both detoxification therapies, especially prior to engaging in panchakarma therapy, is used as a rejuvenative tonic , and used for health maintenance, making it one of the most versatile herbal cleansers and tonifers avaiable. It is also among the oldest continually used formula on the planet, in use for more than 1200 years. This alone makes this formula and its ingredients worth learning about.
In recent years, concerns about quality and benefits of Ayurvedic herbal compounds have been called into question, primarily due to the presence of metal bhasmas in Indian-made tonics. These monographs will show there are quality standards for Ayurvedic herbs. AHP will be the first Western Pharmacopoeia to develop a Triphala formula monograph, making that in itself historic.
We hope you will sincerely consider making a contribution to this important work. For herbal products manufacturers, we invite companies to review various sections of the monograph and will be listed as a reviewer. We encourage sponsors to press release their support of the monograph at the time of sponsorship and again when the monograph is released. In addition, you would be able to include your sponsorship on your website, in presentations, and publications. If your material meets the standards established in the monograph, you would be able to promote your product as AHP Kava quality, which may set it apart from others in the industry. For individuals wishing to contribute, you will be participating in the furtherance of our knowledge base on herbal medicine for future generations, this very fitting for this important Southwest Pacific Island botanical.
Sincerely,
Roy Upton, President
American Herbal Pharmacopoeia
Sebastian Pole, Proprietor
Pukka Herbs
Nomenclature
Identification
Constituents
Therapeutics
Pharmacokinetics
International Status
History
Commercial Sources & Handling
Analytical
Safety Profile
References
* Please note: The full sponsorship goal of the Triphala Monograph project is $37,000. If you would like to give the full sponsorship amount, please contact us and we’ll send you an invoice.